Experiments for taxon Tribulus cistoides (ZYGOPHYLLACEAE)

Experiments (50 results)

Filters
Worktypes (16)
30
24
22
21
17
14
13
10
10
8
7
5
4
3
1
1
No match
Pharmacology (10)
8
2
2
2
1
1
1
1
1
31
No match
Compounds (29)
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
13
No match
Organisms (6)
25
13
8
2
1
1
No match
50 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
181827
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
TRIBULOSIN
155328
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
TYRAMINE,N-TETRACOSANOYL:
1459
IDENTIFICATION IN BY PAPER CHROMATOGRAPHY
Tribulus cistoides (ZYGOPHYLLACEAE)
19107
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tribulus cistoides (ZYGOPHYLLACEAE)
155330
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATATLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
TRIBULOSIN
19113
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155340
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
HECOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-2)-[BETA-GLUCOPYRANOSYL(1-3)]-BETA-GLUCOPYRANOSYL(1-4)-[ALPHA-RHAMNOPYRANSOYL(1-2)]-BETA-GALACTOPYRANOSYL]:
155335
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
HECOGENIN,NEO: 3-O-[BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSYL]:TIGOGENIN,NEO: 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL]:
155324
PHARMACOLOGY OF EXTRACT - IN VIVO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155346
QUANTITATIVE DATATLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
SUCROSE
155339
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-4)-BETA-GLUCOPYRANOSYL(1-3)-[BETA-GLUCOPYRANOSYL(1-2))]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL):
181837
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
PREGNA-4-17(20)-TRANS-DIEN-3-ONE,16(S)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL-OXY:
181836
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-5-ENE-16(S)-22(S)-26-TRIOL,25(S)-1(R)-(ALPHA-L-RHAMNOPYRANOSYL-OXY)-3(R)-(BETA-D-GALACTOPYRANOSYL-OXY):
32905
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
19114
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
19108
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tribulus cistoides (ZYGOPHYLLACEAE)
155341
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
GITOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-4)-BETA-GLUCOPYRANOSYL(1-3)-[BETA-GLUCOPYRANOSYL(1-2)]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL]:
181832
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-4-EN-3-ONE,25(S)-16(S)-[BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GALACTOPYRANOSYL-OXY]-22(S)-26-DIHYDROXY:
155323
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO:
155338
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
CISTOCARDIN
181838
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
PINITOL,(D):
19110
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOGENIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155327
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
TYRAMINE,N-DOCOSANOYL:
181835
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-5-ENE-16(S)-22(S)-DIOL,1(R)-(ALPHA-L-RHAMNOPYRANOSYL-OXY)-3(R)-(BETA-D-GALACTOPYRANOSYL-OXY):
155334
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO: 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL]:
155345
QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
PINITOL,D: (+):
32904
MEDICINAL FOLKLORE REPORTED FOR
CNS STIMULANT ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155342
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
HECOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-2)-[BETA-GLUCOPYRANOSYL(1-3)]-BETA-GLUCOPYRANOSYL(1-4)-[ALPHA-RHAMNOPYRANSOYL(1-2)]-BETA-GALACTOPYRANOSYL]:
19111
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTOR ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
181829
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-4-EN-3-ONE,16(S)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)BETA-D-GALACTOPYRANOSYL-OXY]-22(S)-HYDROXY:
155326
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
HECOGENIN,NEO:
181831
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-4-ENE-3-22-DIONE,25(S)-16(S)-[BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GALACTOPYRANOSYL-OXY]-26-HYDROXY:
155331
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-2)-[BETA-XYLOPYRANOSYL(1-3))]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL]:
155337
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-4)-BETA-GLUCOPYRANOSYL(1-3)-[BETA-GLUCOPYRANOSYL(1-2))]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL):
155344
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
FUROSTAN-3-BETA-26-DIOL,5-ALPHA: 3-O-[BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSYL]-26-(BETA-GLUCOPYRANOSYL)-22-METHOXY: 25(S):
181834
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLESTAN-3-ONE-5(S)-16(S)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSYL_OXY]-22(S)-26-DIHYDROXY:
155333
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
HECOGENIN,NEO: 3-O-[BETA-D-XYLOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSYL]:
181839
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
SUCROSE
32903
MEDICINAL FOLKLORE REPORTED FOR
DIURETIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155329
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
TIGOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-2)-[BETA-XYLOPYRANOSYL(1-3))]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL]:
155343
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
GITOGENIN,NEO: 3-O-[BETA-XYLOPYRANOSYL(1-4)-BETA-GLUCOPYRANOSYL(1-3)-[BETA-GLUCOPYRANOSYL(1-2)]-BETA-GLUCOPYRANOSYL(1-4)-BETA-GALACTOPYRANOSYL]:
181830
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-4-EN-3-ONE,16(S)-[BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GALACTOPYRANOSYL-OXY]-22(S)-HYDROXY:
19112
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE STIMULANT ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
181828
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
TRIBULUS SAPONIN 3
155325
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tribulus cistoides (ZYGOPHYLLACEAE)
GITOGENIN,NEO:
155336
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
CISTOCARDIN
155332
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
TRIBULOSIN
19109
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOGENIC ACTIVITY
Tribulus cistoides (ZYGOPHYLLACEAE)
155347
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Tribulus cistoides (ZYGOPHYLLACEAE)
JASMONIC ACID,5'-(HYDROXY-SULFONYL-OXY):
181833
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tribulus cistoides (ZYGOPHYLLACEAE)
CHOLEST-4-EN-3-ONE,25(S)-16(S)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSYL-OXY]-22(S)-26-DIHYDROXY: